{
  "clinical": {
    "updated_at": "2025-09-16T23:14:08.029Z",
    "clusters": []
  },
  "professional": {
    "updated_at": "2025-09-16T23:14:23.033Z",
    "clusters": [
      {
        "id": "cluster_0",
        "coverage": 1,
        "updated_at": "Tue, 16 Sep 2025 05:17:37 GMT",
        "title": "Expanded scope ‘for anyone except general practice’",
        "neutral_headline": "Expanded scope ‘for anyone except general practice’",
        "items": [
          {
            "source": "newsGP",
            "url": "https://www1.racgp.org.au/newsgp/professional/expanded-scope-for-anyone-except-general-practice?feed=RACGPnewsGPArticles",
            "published_at": "Tue, 16 Sep 2025 05:17:37 GMT",
            "title": "Expanded scope ‘for anyone except general practice’",
            "standfirst": "One GP is speaking out about concerns doctors are being left behind in Australia&rsquo;s healthcare system, warning of dire consequences for both the sector and wider community.",
            "content": "One GP is speaking out about concerns doctors are being left behind in Australia&rsquo;s healthcare system, warning of dire consequences for both the sector and wider community.",
            "feed_position": 0,
            "image_url": "https://www1.racgp.org.au/getattachment/2dec20f8-dba5-4550-a58b-b7505b9f2616/Expanded-scope-for-anyone-except-general-practice.aspx"
          }
        ],
        "featured_image": "https://www1.racgp.org.au/getattachment/2dec20f8-dba5-4550-a58b-b7505b9f2616/Expanded-scope-for-anyone-except-general-practice.aspx",
        "ai_summary": [
          "A general practitioner is raising concerns about the healthcare system.",
          "The GP warns of dire consequences for the sector and community.",
          "The GP believes doctors are being left behind in Australia.",
          "The GP is speaking out about the expanded scope of practice.",
          "The GP is concerned about the future of general practice."
        ]
      },
      {
        "id": "cluster_1",
        "coverage": 1,
        "updated_at": "Tue, 16 Sep 2025 05:09:06 GMT",
        "title": "More GPs ‘sorely needed’ in the NT",
        "neutral_headline": "More GPs ‘sorely needed’ in the NT",
        "items": [
          {
            "source": "newsGP",
            "url": "https://www1.racgp.org.au/newsgp/professional/more-gps-sorely-needed-in-the-nt?feed=RACGPnewsGPArticles",
            "published_at": "Tue, 16 Sep 2025 05:09:06 GMT",
            "title": "More GPs ‘sorely needed’ in the NT",
            "standfirst": "The increasing importance of generalist skills was a recurring theme at a conference in Darwin on the weekend.",
            "content": "The increasing importance of generalist skills was a recurring theme at a conference in Darwin on the weekend.",
            "feed_position": 1,
            "image_url": "https://www1.racgp.org.au/getattachment/b04f9012-4e48-41b1-999a-8114dfff36b6/More-GPs-sorely-needed-in-the-NT.aspx"
          }
        ],
        "featured_image": "https://www1.racgp.org.au/getattachment/b04f9012-4e48-41b1-999a-8114dfff36b6/More-GPs-sorely-needed-in-the-NT.aspx",
        "ai_summary": [
          "A conference in Darwin highlighted the need for more GPs.",
          "The conference emphasized the importance of generalist skills.",
          "The need for more GPs was a recurring theme.",
          "The conference took place over the weekend.",
          "The conference focused on healthcare in the Northern Territory."
        ]
      },
      {
        "id": "cluster_2",
        "coverage": 1,
        "updated_at": "Tue, 16 Sep 2025 04:47:40 GMT",
        "title": "Surge in most STIs over the past 10 years",
        "neutral_headline": "Surge in most STIs over the past 10 years",
        "items": [
          {
            "source": "newsGP",
            "url": "https://www1.racgp.org.au/newsgp/clinical/surge-in-most-stis-over-the-past-10-years?feed=RACGPnewsGPArticles",
            "published_at": "Tue, 16 Sep 2025 04:47:40 GMT",
            "title": "Surge in most STIs over the past 10 years",
            "standfirst": "Syphilis and gonorrhoea diagnoses have doubled, chlamydia remains high, but HIV has declined, new data indicates.",
            "content": "Syphilis and gonorrhoea diagnoses have doubled, chlamydia remains high, but HIV has declined, new data indicates.",
            "feed_position": 2,
            "image_url": "https://www1.racgp.org.au/getattachment/60d1eb46-13c0-4f15-bae1-7d2215d1324c/Surge-in-most-STIs-over-the-past-10-years.aspx"
          }
        ],
        "featured_image": "https://www1.racgp.org.au/getattachment/60d1eb46-13c0-4f15-bae1-7d2215d1324c/Surge-in-most-STIs-over-the-past-10-years.aspx",
        "ai_summary": [
          "New data indicates a surge in most sexually transmitted infections.",
          "Syphilis and gonorrhoea diagnoses have doubled in the last decade.",
          "Chlamydia rates remain high according to the new data.",
          "HIV diagnoses have declined over the past ten years.",
          "The data provides insights into STI trends."
        ]
      },
      {
        "id": "cluster_3",
        "coverage": 1,
        "updated_at": "Tue, 16 Sep 2025 04:20:18 GMT",
        "title": "Empowering access to key health information: my health app",
        "neutral_headline": "Empowering access to key health information: my health app",
        "items": [
          {
            "source": "newsGP",
            "url": "https://www1.racgp.org.au/newsgp/professional/empowering-access-to-key-health-information-my-hea?feed=RACGPnewsGPArticles",
            "published_at": "Tue, 16 Sep 2025 04:20:18 GMT",
            "title": "Empowering access to key health information: my health app",
            "standfirst": "SPONSORED: The app is transforming how people engage with their key health data by providing secure, on-demand access to My Health Record.",
            "content": "SPONSORED: The app is transforming how people engage with their key health data by providing secure, on-demand access to My Health Record.",
            "feed_position": 3,
            "image_url": "https://www1.racgp.org.au/getattachment/76da9834-6fd6-4073-bb67-7a80e1ca1373/Empowering-access-to-key-health-information-my-health-app.aspx"
          }
        ],
        "featured_image": "https://www1.racgp.org.au/getattachment/76da9834-6fd6-4073-bb67-7a80e1ca1373/Empowering-access-to-key-health-information-my-health-app.aspx",
        "ai_summary": [
          "The app provides secure, on-demand access to My Health Record for users.",
          "It aims to transform how people engage with their key health data.",
          "The app is designed to empower users with access to their health information.",
          "It offers a platform for users to manage their health data effectively.",
          "The app is a tool for individuals to take control of their health records."
        ]
      },
      {
        "id": "cluster_4",
        "coverage": 1,
        "updated_at": "Mon, 15 Sep 2025 07:03:39 GMT",
        "title": "AHPRA should not handle minor complaints: Review",
        "neutral_headline": "AHPRA should not handle minor complaints: Review",
        "items": [
          {
            "source": "newsGP",
            "url": "https://www1.racgp.org.au/newsgp/professional/ahpra-should-not-handle-minor-complaints-review?feed=RACGPnewsGPArticles",
            "published_at": "Mon, 15 Sep 2025 07:03:39 GMT",
            "title": "AHPRA should not handle minor complaints: Review",
            "standfirst": "The suggestion was among 26 recommendations for an &lsquo;ambitious&rsquo; suite of reforms in a review of the regulation of health professionals.",
            "content": "The suggestion was among 26 recommendations for an &lsquo;ambitious&rsquo; suite of reforms in a review of the regulation of health professionals.",
            "feed_position": 4,
            "image_url": "https://www1.racgp.org.au/getattachment/acdacb48-834f-491b-91a0-20b0d4789df0/AHPRA-should-not-handle-minor-complaints-Review.aspx"
          }
        ],
        "featured_image": "https://www1.racgp.org.au/getattachment/acdacb48-834f-491b-91a0-20b0d4789df0/AHPRA-should-not-handle-minor-complaints-Review.aspx",
        "ai_summary": [
          "A review suggested AHPRA should not handle minor complaints.",
          "This suggestion was one of 26 recommendations for reforms.",
          "The reforms aim to change the regulation of health professionals.",
          "The review is described as proposing an ambitious suite of changes.",
          "The recommendations seek to improve the current regulatory framework."
        ]
      }
    ]
  },
  "patient_signals": {
    "updated_at": "2025-09-16T23:14:18.146Z",
    "clusters": [
      {
        "id": "cluster_0",
        "coverage": 1,
        "updated_at": "Tue, 16 Sep 2025 23:01:19 GMT",
        "title": "Systemic racism affects maternity care for black women in England, say MPs",
        "neutral_headline": "Systemic racism affects maternity care for black women in England",
        "items": [
          {
            "source": "Guardian Health",
            "url": "https://www.theguardian.com/society/2025/sep/17/systemic-racism-affects-maternity-care-for-black-women-in-england-say-mps",
            "published_at": "Tue, 16 Sep 2025 23:01:19 GMT",
            "title": "Systemic racism affects maternity care for black women in England, say MPs",
            "standfirst": "Commons committee finds women’s concerns not taken seriously due to bias, stereotyping and racist assumptionsBlack women in England are still facing poorer outcomes in their maternity care due to systemic racism, alongside failures in leadership and data collection, according to a group of MPs.Across the UK, black women are more than twice as likely to die in childbirth compared with their white counterparts, while babies born to black mothers are at an increased risk of stillbirth. Continue reading...",
            "content": "Commons committee finds women’s concerns not taken seriously due to bias, stereotyping and racist assumptionsBlack women in England are still facing poorer outcomes in their maternity care due to systemic racism, alongside failures in leadership and data collection, according to a group of MPs.Across the UK, black women are more than twice as likely to die in childbirth compared with their white counterparts, while babies born to black mothers are at an increased risk of stillbirth. Continue reading...",
            "feed_position": 0
          }
        ],
        "ai_summary": [
          "A Commons committee found black women face poorer maternity outcomes.",
          "Bias, stereotyping, and racist assumptions contribute to the disparities.",
          "Black women are more than twice as likely to die in childbirth.",
          "Babies born to black mothers face increased risk of stillbirth.",
          "Failures in leadership and data collection also contribute to the problem."
        ]
      },
      {
        "id": "cluster_1",
        "coverage": 1,
        "updated_at": "Tue, 16 Sep 2025 22:01:17 GMT",
        "title": "Daily weight loss pill can help cut body weight by a fifth, trial shows",
        "neutral_headline": "Daily weight loss pill can help cut body weight by a fifth",
        "items": [
          {
            "source": "Guardian Health",
            "url": "https://www.theguardian.com/society/2025/sep/16/daily-weight-loss-pill-orforglipron-cut-body-weight-by-a-fifth",
            "published_at": "Tue, 16 Sep 2025 22:01:17 GMT",
            "title": "Daily weight loss pill can help cut body weight by a fifth, trial shows",
            "standfirst": "One in five people who took orforglipron once a day for 72 weeks lost 20% or more of their weight, maker Eli Lilly saysA daily pill for weight loss can help people reduce their body weight by as much as a fifth, according to a trial that could pave the way for millions more people to shed pounds.The drug, called orforglipron, is manufactured by Eli Lilly and targets the same GLP-1 receptors as weight loss injections such as Mounjaro and Wegovy. In a trial of 3,127 adults, one in five people who took the once-a-day tablet for 72 weeks lost 20% or more of their body weight. Continue reading...",
            "content": "One in five people who took orforglipron once a day for 72 weeks lost 20% or more of their weight, maker Eli Lilly saysA daily pill for weight loss can help people reduce their body weight by as much as a fifth, according to a trial that could pave the way for millions more people to shed pounds.The drug, called orforglipron, is manufactured by Eli Lilly and targets the same GLP-1 receptors as weight loss injections such as Mounjaro and Wegovy. In a trial of 3,127 adults, one in five people who took the once-a-day tablet for 72 weeks lost 20% or more of their body weight. Continue reading...",
            "feed_position": 1
          }
        ],
        "ai_summary": [
          "Orforglipron, a daily pill, can help people lose weight.",
          "One in five people lost 20% or more of their weight in a trial.",
          "The trial lasted 72 weeks and involved 3,127 adults.",
          "The drug targets the same GLP-1 receptors as injections.",
          "Eli Lilly manufactures orforglipron, the weight loss pill."
        ]
      },
      {
        "id": "cluster_2",
        "coverage": 1,
        "updated_at": "Tue, 16 Sep 2025 18:07:29 GMT",
        "title": "UK set on resolving standoff with big pharma, science minister says",
        "neutral_headline": "UK set on resolving standoff with big pharma, science minister says",
        "items": [
          {
            "source": "Guardian Health",
            "url": "https://www.theguardian.com/business/2025/sep/16/nhs-must-reverse-decline-medicines-investment-science-minister-patrick-vallance",
            "published_at": "Tue, 16 Sep 2025 18:07:29 GMT",
            "title": "UK set on resolving standoff with big pharma, science minister says",
            "standfirst": "Patrick Vallance says relations must improve and NHS has to reverse decline in drugs investmentThe UK is determined to resolve its standoff with the pharmaceutical industry and reverse a 10-year decline in NHS spending on medicines, the science minister has told MPs after a string of drugmakers cancelled projects worth nearly £2bn.Patrick Vallance, a former executive at drugmaker GSK, said the country needed to increase spending on medicines and reverse a decade of declining investment. Continue reading...",
            "content": "Patrick Vallance says relations must improve and NHS has to reverse decline in drugs investmentThe UK is determined to resolve its standoff with the pharmaceutical industry and reverse a 10-year decline in NHS spending on medicines, the science minister has told MPs after a string of drugmakers cancelled projects worth nearly £2bn.Patrick Vallance, a former executive at drugmaker GSK, said the country needed to increase spending on medicines and reverse a decade of declining investment. Continue reading...",
            "feed_position": 2
          }
        ],
        "ai_summary": [
          "The UK aims to resolve its standoff with the pharmaceutical industry.",
          "The government wants to reverse decline in NHS drug spending.",
          "The science minister is Patrick Vallance, a former drugmaker executive.",
          "The UK needs to increase spending on medicines.",
          "A decade of declining investment in medicines needs to be reversed."
        ]
      },
      {
        "id": "cluster_3",
        "coverage": 1,
        "updated_at": "Tue, 16 Sep 2025 16:43:07 GMT",
        "title": "Thousands of opioid deaths missed off official figures",
        "neutral_headline": "Thousands of opioid deaths missed off official figures",
        "items": [
          {
            "source": "BBC Health",
            "url": "https://www.bbc.com/news/articles/cg7dzmyjrjzo?at_medium=RSS&at_campaign=rss",
            "published_at": "Tue, 16 Sep 2025 16:43:07 GMT",
            "title": "Thousands of opioid deaths missed off official figures",
            "standfirst": "The error - affecting England and Wales - raises concerns about the impact on the government's approach to drug deaths.",
            "content": "The error - affecting England and Wales - raises concerns about the impact on the government's approach to drug deaths.",
            "feed_position": 0,
            "image_url": "https://ichef.bbci.co.uk/ace/standard/240/cpsprodpb/6615/live/8f926d00-9237-11f0-a06c-f10cee3fef66.jpg"
          }
        ],
        "featured_image": "https://ichef.bbci.co.uk/ace/standard/240/cpsprodpb/6615/live/8f926d00-9237-11f0-a06c-f10cee3fef66.jpg",
        "ai_summary": [
          "An error in official figures affected England and Wales.",
          "The error raises concerns about the government's approach.",
          "The error involves the undercounting of opioid-related deaths.",
          "The impact on the government's approach is a key concern.",
          "The error highlights the importance of accurate data."
        ]
      },
      {
        "id": "cluster_4",
        "coverage": 1,
        "updated_at": "Tue, 16 Sep 2025 15:43:29 GMT",
        "title": "US health officials to revisit vaccine policies using anti-vax tactics, experts warn",
        "neutral_headline": "US health officials to revisit vaccine policies using anti-vax tactics, experts warn",
        "items": [
          {
            "source": "Guardian Health",
            "url": "https://www.theguardian.com/society/2025/sep/16/vaccine-recommendations-anti-vax-data",
            "published_at": "Tue, 16 Sep 2025 15:43:29 GMT",
            "title": "US health officials to revisit vaccine policies using anti-vax tactics, experts warn",
            "standfirst": "Data public health experts say is worrisome will reportedly be presented to ACIP later this week before vote on shotsUS health officials are reportedly planning to release data on child deaths and serious side effects they would attribute to Covid-19 vaccines, raising alarm among public health experts who say the publicly available data does not support these claims and the report may lead to increased anti-vaccine sentiment.Independent advisers for the US Centers for Disease Control and Prevention (CDC) later this week plan to revisit recommendations for Covid shots as well as vaccines for measles and hepatitis B. Continue reading...",
            "content": "Data public health experts say is worrisome will reportedly be presented to ACIP later this week before vote on shotsUS health officials are reportedly planning to release data on child deaths and serious side effects they would attribute to Covid-19 vaccines, raising alarm among public health experts who say the publicly available data does not support these claims and the report may lead to increased anti-vaccine sentiment.Independent advisers for the US Centers for Disease Control and Prevention (CDC) later this week plan to revisit recommendations for Covid shots as well as vaccines for measles and hepatitis B. Continue reading...",
            "feed_position": 3
          }
        ],
        "ai_summary": [
          "US officials plan to release data on child deaths and side effects.",
          "Experts warn the data may increase anti-vaccine sentiment.",
          "Independent advisors will revisit vaccine recommendations.",
          "Recommendations for Covid shots, measles, and hepatitis B will be reviewed.",
          "The CDC is the agency involved in the vaccine recommendations."
        ]
      },
      {
        "id": "cluster_5",
        "coverage": 1,
        "updated_at": "Tue, 16 Sep 2025 15:00:11 GMT",
        "title": "Long Covid linked to heavier periods and risk of iron deficiency",
        "neutral_headline": "Long Covid linked to heavier periods and risk of iron deficiency",
        "items": [
          {
            "source": "Guardian Health",
            "url": "https://www.theguardian.com/society/2025/sep/16/long-covid-linked-heavier-periods-risk-iron-deficiency",
            "published_at": "Tue, 16 Sep 2025 15:00:11 GMT",
            "title": "Long Covid linked to heavier periods and risk of iron deficiency",
            "standfirst": "Survey of 12,000 women also revealed severity of long Covid symptoms rose and fell across menstrual cycleWomen with long Covid are prone to longer, heavier periods, which could put them at greater risk of iron deficiency that exacerbates common symptoms of the condition, doctors say.The findings emerged from a UK survey of more than 12,000 women, which also found that the severity of long Covid symptoms rose and fell across the menstrual cycle and became worse when women had their periods. Continue reading...",
            "content": "Survey of 12,000 women also revealed severity of long Covid symptoms rose and fell across menstrual cycleWomen with long Covid are prone to longer, heavier periods, which could put them at greater risk of iron deficiency that exacerbates common symptoms of the condition, doctors say.The findings emerged from a UK survey of more than 12,000 women, which also found that the severity of long Covid symptoms rose and fell across the menstrual cycle and became worse when women had their periods. Continue reading...",
            "feed_position": 4
          }
        ],
        "ai_summary": [
          "Women with long Covid may experience heavier periods.",
          "Heavier periods could increase the risk of iron deficiency.",
          "A UK survey involved over 12,000 women.",
          "Long Covid symptoms fluctuate with the menstrual cycle.",
          "Symptoms worsen during women's menstrual periods."
        ]
      },
      {
        "id": "cluster_6",
        "coverage": 1,
        "updated_at": "Tue, 16 Sep 2025 12:00:06 GMT",
        "title": "California nurses decry Ice presence at hospitals: ‘Interfering with patient care’",
        "neutral_headline": "California nurses decry Ice presence at hospitals",
        "items": [
          {
            "source": "Guardian Health",
            "url": "https://www.theguardian.com/us-news/2025/sep/16/california-ice-hospitals-patient-care",
            "published_at": "Tue, 16 Sep 2025 12:00:06 GMT",
            "title": "California nurses decry Ice presence at hospitals: ‘Interfering with patient care’",
            "standfirst": "Caregiving staff say agents are bringing in patients, often denying them visitors and speaking on their behalf to staffDianne Sposito, a 69-year-old nurse, is laser-focused on providing care to anyone who enters the UCLA emergency room in southern California, where she works.That task was made difficult though one week in June, she said, when a federal immigration agent blocked her from treating an immigrant who was screaming just a few feet in front of her in the hospital. Continue reading...",
            "content": "Caregiving staff say agents are bringing in patients, often denying them visitors and speaking on their behalf to staffDianne Sposito, a 69-year-old nurse, is laser-focused on providing care to anyone who enters the UCLA emergency room in southern California, where she works.That task was made difficult though one week in June, she said, when a federal immigration agent blocked her from treating an immigrant who was screaming just a few feet in front of her in the hospital. Continue reading...",
            "feed_position": 5
          }
        ],
        "ai_summary": [
          "Nurses in California are critical of ICE presence in hospitals.",
          "Agents are bringing in patients and denying them visitors.",
          "Agents are speaking on behalf of patients to staff.",
          "A nurse described difficulties in providing care.",
          "The nurse works in the UCLA emergency room."
        ]
      },
      {
        "id": "cluster_7",
        "coverage": 1,
        "updated_at": "Tue, 16 Sep 2025 10:00:35 GMT",
        "title": "Mississippi declares infant deaths emergency as CDC program that could have helped is halted",
        "neutral_headline": "Mississippi declares infant deaths emergency as CDC program that could have helped is halted",
        "items": [
          {
            "source": "Guardian Health",
            "url": "https://www.theguardian.com/us-news/2025/sep/16/mississippi-infant-deaths-cdc-prams",
            "published_at": "Tue, 16 Sep 2025 10:00:35 GMT",
            "title": "Mississippi declares infant deaths emergency as CDC program that could have helped is halted",
            "standfirst": "State forced to stop gathering critical data on pregnancy experiences after Trump administration’s shakeupThe Trump administration’s shakeup of the Centers for Disease Control and Prevention (CDC) has forced Mississippi to stop gathering critical data on women’s experiences before, during and after pregnancy – even as the state recently declared a public health emergency over its surging infant mortality rate.Mississippi has suspended data collection for Pregnancy Risk Assessment Monitoring System (Prams), a national database that has been integral to policymaking on maternal and infant health for nearly four decades, the Guardian has learned. Continue reading...",
            "content": "State forced to stop gathering critical data on pregnancy experiences after Trump administration’s shakeupThe Trump administration’s shakeup of the Centers for Disease Control and Prevention (CDC) has forced Mississippi to stop gathering critical data on women’s experiences before, during and after pregnancy – even as the state recently declared a public health emergency over its surging infant mortality rate.Mississippi has suspended data collection for Pregnancy Risk Assessment Monitoring System (Prams), a national database that has been integral to policymaking on maternal and infant health for nearly four decades, the Guardian has learned. Continue reading...",
            "feed_position": 6
          }
        ],
        "ai_summary": [
          "Mississippi declared an infant deaths public health emergency.",
          "The state stopped gathering data on pregnancy experiences.",
          "The Trump administration's shakeup caused the data halt.",
          "The data collection was part of the Prams program.",
          "Prams is a national database for maternal and infant health."
        ]
      },
      {
        "id": "cluster_8",
        "coverage": 1,
        "updated_at": "Tue, 16 Sep 2025 07:00:01 GMT",
        "title": "Who benefits if NHS drug prices soar? Donald Trump and big pharma. Just one more way he’s menacing Britain | Polly Toynbee",
        "neutral_headline": "Who benefits if NHS drug prices soar? Donald Trump and big pharma. Just one more way he’s menacing Britain | Polly Toynbee",
        "items": [
          {
            "source": "Guardian Health",
            "url": "https://www.theguardian.com/commentisfree/2025/sep/16/nhs-drug-prices-donald-trump-big-pharma-britain-labour",
            "published_at": "Tue, 16 Sep 2025 07:00:01 GMT",
            "title": "Who benefits if NHS drug prices soar? Donald Trump and big pharma. Just one more way he’s menacing Britain | Polly Toynbee",
            "standfirst": "The NHS needs cheap drugs, and our economy needs a thriving pharma industry. The president threatens both – no wonder Labour is grovelling to himGoverning in the era of Donald Trump has been Labour’s miserable misfortune. As our prime minister and king grovel to the global bully with royal folderol this week, we will probably feel the full humiliation of the would-be American king.The recent blow to British life sciences is a brutal example of our serfdom. Trump’s threat to put a 250% tariff on medicines made abroad by pharmaceutical companies, unless they move their factories, research and legions of jobs to the US, is driving out the UK pharma industry. What’s to stop him? AstraZeneca has ditched a £450m vaccine plant in Liverpool. In a shock announcement last week, the US drugmaker Merck axed a half-built, £1bn London research facility next to the Crick Institute it was destined to work with. Eli Lilly is pausing investment in the UK while Novartis is understood to be “keeping its investments under review”.Polly Toynbee is a Guardian columnist Continue reading...",
            "content": "The NHS needs cheap drugs, and our economy needs a thriving pharma industry. The president threatens both – no wonder Labour is grovelling to himGoverning in the era of Donald Trump has been Labour’s miserable misfortune. As our prime minister and king grovel to the global bully with royal folderol this week, we will probably feel the full humiliation of the would-be American king.The recent blow to British life sciences is a brutal example of our serfdom. Trump’s threat to put a 250% tariff on medicines made abroad by pharmaceutical companies, unless they move their factories, research and legions of jobs to the US, is driving out the UK pharma industry. What’s to stop him? AstraZeneca has ditched a £450m vaccine plant in Liverpool. In a shock announcement last week, the US drugmaker Merck axed a half-built, £1bn London research facility next to the Crick Institute it was destined to work with. Eli Lilly is pausing investment in the UK while Novartis is understood to be “keeping its investments under review”.Polly Toynbee is a Guardian columnist Continue reading...",
            "feed_position": 7
          },
          {
            "source": "Guardian Health",
            "url": "https://www.theguardian.com/business/2025/sep/16/big-pharma-firms-uk-investment-trump-msd-eli-lilly-astrazeneca",
            "published_at": "Tue, 16 Sep 2025 05:00:29 GMT",
            "title": "Big pharma firms have paused nearly £2bn in UK investments this year",
            "standfirst": "Government’s plans in disarray before Trump talks as MSD, Eli Lilly and AstraZeneca moves prompt job fearsBig pharmaceutical companies have ditched or paused nearly £2bn in planned UK investments so far this year, causing “suffering” to patients, as ministers gear up for discussions with Donald Trump amid a row over drug pricing.The government’s plan for the life science sector, a key pillar of the economy, has been thrown into disarray, after US drugmaker MSD’s shock announcement last Wednesday that it would scrap its £1bn London research centre. Two days later, AstraZeneca decided to halt a planned £200m expansion of its research facilities in Cambridge. Continue reading...",
            "content": "Government’s plans in disarray before Trump talks as MSD, Eli Lilly and AstraZeneca moves prompt job fearsBig pharmaceutical companies have ditched or paused nearly £2bn in planned UK investments so far this year, causing “suffering” to patients, as ministers gear up for discussions with Donald Trump amid a row over drug pricing.The government’s plan for the life science sector, a key pillar of the economy, has been thrown into disarray, after US drugmaker MSD’s shock announcement last Wednesday that it would scrap its £1bn London research centre. Two days later, AstraZeneca decided to halt a planned £200m expansion of its research facilities in Cambridge. Continue reading...",
            "feed_position": 8
          }
        ],
        "ai_summary": [
          "Big pharma firms have paused nearly £2bn in UK investments.",
          "The government's plan for life sciences is in disarray.",
          "Donald Trump threatens tariffs on medicines made abroad.",
          "AstraZeneca halted a £200m expansion in Cambridge.",
          "MSD scrapped a £1bn London research center."
        ]
      },
      {
        "id": "cluster_9",
        "coverage": 1,
        "updated_at": "Tue, 16 Sep 2025 05:58:12 GMT",
        "title": "How gaming can be good for your mental health",
        "neutral_headline": "How gaming can be good for your mental health",
        "items": [
          {
            "source": "BBC Health",
            "url": "https://www.bbc.com/news/videos/c0jq7n2y3jvo?at_medium=RSS&at_campaign=rss",
            "published_at": "Tue, 16 Sep 2025 05:58:12 GMT",
            "title": "How gaming can be good for your mental health",
            "standfirst": "Psychologist and gaming expert Nick Ballou has five ways how gaming can boost your mental health and wellbeing.",
            "content": "Psychologist and gaming expert Nick Ballou has five ways how gaming can boost your mental health and wellbeing.",
            "feed_position": 99,
            "image_url": "https://ichef.bbci.co.uk/ace/standard/240/cpsprodpb/82d6/live/42958d40-9258-11f0-b391-6936825093bd.jpg"
          }
        ],
        "featured_image": "https://ichef.bbci.co.uk/ace/standard/240/cpsprodpb/82d6/live/42958d40-9258-11f0-b391-6936825093bd.jpg",
        "ai_summary": [
          "A psychologist and gaming expert offers five ways gaming helps.",
          "Gaming can boost mental health and overall wellbeing.",
          "The article focuses on the positive aspects of gaming.",
          "The expert's insights provide guidance on gaming benefits.",
          "The article aims to promote the positive effects of gaming."
        ]
      },
      {
        "id": "cluster_10",
        "coverage": 1,
        "updated_at": "Tue, 16 Sep 2025 05:47:54 GMT",
        "title": "Let's have a conversation about periods",
        "neutral_headline": "Let's have a conversation about periods",
        "items": [
          {
            "source": "BBC Health",
            "url": "https://www.bbc.com/news/videos/cz9jynyde1qo?at_medium=RSS&at_campaign=rss",
            "published_at": "Tue, 16 Sep 2025 05:47:54 GMT",
            "title": "Let's have a conversation about periods",
            "standfirst": "Three teenage girls talk to 5 Live about the importance of safe and open conversations on topics such as hormones, periods and mental health.",
            "content": "Three teenage girls talk to 5 Live about the importance of safe and open conversations on topics such as hormones, periods and mental health.",
            "feed_position": 85,
            "image_url": "https://ichef.bbci.co.uk/ace/standard/240/cpsprodpb/cc5f/live/28b0be00-9261-11f0-84c8-99de564f0440.jpg"
          }
        ],
        "featured_image": "https://ichef.bbci.co.uk/ace/standard/240/cpsprodpb/cc5f/live/28b0be00-9261-11f0-84c8-99de564f0440.jpg",
        "ai_summary": [
          "Three teenage girls discuss periods on 5 Live.",
          "They talk about the importance of open conversations.",
          "Topics include hormones, periods, and mental health.",
          "The discussion aims to promote safe conversations.",
          "The program focuses on teenage girls' experiences."
        ]
      },
      {
        "id": "cluster_11",
        "coverage": 1,
        "updated_at": "Tue, 16 Sep 2025 05:14:18 GMT",
        "title": "Severe inequality in London for weight loss drugs",
        "neutral_headline": "Severe inequality in London for weight loss drugs",
        "items": [
          {
            "source": "BBC Health",
            "url": "https://www.bbc.com/news/articles/c5y5689zlzvo?at_medium=RSS&at_campaign=rss",
            "published_at": "Tue, 16 Sep 2025 05:14:18 GMT",
            "title": "Severe inequality in London for weight loss drugs",
            "standfirst": "Interest in the drugs has risen but patients face a \"postcode lottery\" when trying to access them.",
            "content": "Interest in the drugs has risen but patients face a \"postcode lottery\" when trying to access them.",
            "feed_position": 3,
            "image_url": "https://ichef.bbci.co.uk/ace/standard/240/cpsprodpb/8733/live/f1e4e300-9225-11f0-8fd6-f3e5d0b160a2.jpg"
          }
        ],
        "featured_image": "https://ichef.bbci.co.uk/ace/standard/240/cpsprodpb/8733/live/f1e4e300-9225-11f0-8fd6-f3e5d0b160a2.jpg",
        "ai_summary": [
          "Interest in weight loss drugs has increased in London.",
          "Patients face a \"postcode lottery\" for access.",
          "Access to the drugs is not equal across London.",
          "The article highlights inequalities in healthcare access.",
          "The focus is on the availability of weight loss drugs."
        ]
      },
      {
        "id": "cluster_12",
        "coverage": 1,
        "updated_at": "Mon, 15 Sep 2025 20:46:05 GMT",
        "title": "First group of children from Gaza arrive in UK for life-saving NHS treatment",
        "neutral_headline": "First group of children from Gaza arrive in UK for life-saving NHS treatment",
        "items": [
          {
            "source": "Guardian Health",
            "url": "https://www.theguardian.com/world/2025/sep/15/first-group-of-children-from-gaza-arrive-in-uk-for-life-saving-nhs-treatment",
            "published_at": "Mon, 15 Sep 2025 20:46:05 GMT",
            "title": "First group of children from Gaza arrive in UK for life-saving NHS treatment",
            "standfirst": "Care and support package, including housing, will help 30-50 young Palestinians for an initial two yearsThe first group of children from Gaza have arrived in the UK for specialist life-saving treatment on the NHS, the Guardian understands.Yvette Cooper, the foreign secretary, informed the parliamentary Labour party on Monday evening about the development. On arrival in the UK, the patients and their families have been granted access to NHS treatment, appropriate housing and comprehensive support services for an initial two-year period. Continue reading...",
            "content": "Care and support package, including housing, will help 30-50 young Palestinians for an initial two yearsThe first group of children from Gaza have arrived in the UK for specialist life-saving treatment on the NHS, the Guardian understands.Yvette Cooper, the foreign secretary, informed the parliamentary Labour party on Monday evening about the development. On arrival in the UK, the patients and their families have been granted access to NHS treatment, appropriate housing and comprehensive support services for an initial two-year period. Continue reading...",
            "feed_position": 9
          }
        ],
        "ai_summary": [
          "The first group of children from Gaza arrived in the UK.",
          "They will receive specialist life-saving treatment.",
          "The patients and families have access to NHS treatment.",
          "They will receive housing and support services.",
          "The initial support period is for two years."
        ]
      },
      {
        "id": "cluster_13",
        "coverage": 1,
        "updated_at": "Mon, 15 Sep 2025 18:44:27 GMT",
        "title": "Doctor who left patient during operation to have sex with nurse allowed to practise",
        "neutral_headline": "Doctor's Misconduct Leads to Tribunal Ruling on Risk",
        "items": [
          {
            "source": "Guardian Health",
            "url": "https://www.theguardian.com/uk-news/2025/sep/15/doctor-who-left-patient-during-operation-to-have-sex-allowed-to-practise",
            "published_at": "Mon, 15 Sep 2025 18:44:27 GMT",
            "title": "Doctor who left patient during operation to have sex with nurse allowed to practise",
            "standfirst": "Medical tribunal rules ‘very low risk’ of Suhail Anjum, who had been dismissed by hospital in Greater Manchester, repeating behaviourA doctor who left a patient midway through an operation to have sex with a nurse is at “very low risk” of repeating his serious misconduct, a medical tribunal has ruled.Dr Suhail Anjum, 44, and the unnamed nurse were caught in a “compromising position” by a colleague who walked in on the pair at Tameside hospital. The consultant anaesthetist had asked another nursing colleague to monitor the male patient, who was under general anaesthetic, so he could go to the bathroom. Continue reading...",
            "content": "Medical tribunal rules ‘very low risk’ of Suhail Anjum, who had been dismissed by hospital in Greater Manchester, repeating behaviourA doctor who left a patient midway through an operation to have sex with a nurse is at “very low risk” of repeating his serious misconduct, a medical tribunal has ruled.Dr Suhail Anjum, 44, and the unnamed nurse were caught in a “compromising position” by a colleague who walked in on the pair at Tameside hospital. The consultant anaesthetist had asked another nursing colleague to monitor the male patient, who was under general anaesthetic, so he could go to the bathroom. Continue reading...",
            "feed_position": 10
          }
        ],
        "ai_summary": [
          "A doctor left a patient during surgery to have sex with a nurse, according to reports.",
          "The medical tribunal determined the doctor posed a \"very low risk\" of repeating the behavior.",
          "The incident occurred at Tameside hospital, where the doctor was an anaesthetist.",
          "A colleague discovered the doctor and nurse in a \"compromising position\" during the event.",
          "The doctor had asked another nurse to monitor the patient under general anaesthetic."
        ]
      },
      {
        "id": "cluster_14",
        "coverage": 1,
        "updated_at": "Mon, 15 Sep 2025 17:45:39 GMT",
        "title": "The Guardian view on Merck’s exit: Britain’s biopharma strategy stalls in the face of China’s rise | Editorial",
        "neutral_headline": "Merck's Exit from UK Reflects Broader Shift in Innovation",
        "items": [
          {
            "source": "Guardian Health",
            "url": "https://www.theguardian.com/commentisfree/2025/sep/15/the-guardian-view-on-mercks-exit-britains-biopharma-strategy-stalls-in-the-face-of-chinas-rise",
            "published_at": "Mon, 15 Sep 2025 17:45:39 GMT",
            "title": "The Guardian view on Merck’s exit: Britain’s biopharma strategy stalls in the face of China’s rise | Editorial",
            "standfirst": "The industry’s retreat from the UK reflects a deeper shift about how Beijing is rewriting the rules of innovationWhen Merck abruptly scrapped its billion-pound London research hub last week, critics blamed Britain’s lacklustre support for life sciences and a Scrooge-like grip on NHS drug prices. But one important factor may have been missed. That Merck, which is also cutting jobs elsewhere – 6,000 globally – is recalibrating not just in response to the UK or the US, but to China.Merck’s cash cow is pembrolizumab (brand name Keytruda), an immunotherapy drug launched in 2014 that has successfully treated advanced melanoma, head and neck, lung, cervical and other cancers. It blocks an antibody called PD-1, teaching the immune system to fight the cancer. Because some patients are out of other options, the results sometimes seem miraculous.Do you have an opinion on the issues raised in this article? If you would like to submit a response of up to 300 words by email to be considered for publication in our letters section, please click here. Continue reading...",
            "content": "The industry’s retreat from the UK reflects a deeper shift about how Beijing is rewriting the rules of innovationWhen Merck abruptly scrapped its billion-pound London research hub last week, critics blamed Britain’s lacklustre support for life sciences and a Scrooge-like grip on NHS drug prices. But one important factor may have been missed. That Merck, which is also cutting jobs elsewhere – 6,000 globally – is recalibrating not just in response to the UK or the US, but to China.Merck’s cash cow is pembrolizumab (brand name Keytruda), an immunotherapy drug launched in 2014 that has successfully treated advanced melanoma, head and neck, lung, cervical and other cancers. It blocks an antibody called PD-1, teaching the immune system to fight the cancer. Because some patients are out of other options, the results sometimes seem miraculous.Do you have an opinion on the issues raised in this article? If you would like to submit a response of up to 300 words by email to be considered for publication in our letters section, please click here. Continue reading...",
            "feed_position": 11
          }
        ],
        "ai_summary": [
          "Merck scrapped its billion-pound London research hub, citing various factors.",
          "The company is also cutting 6,000 jobs globally, indicating a recalibration.",
          "Merck's key product is pembrolizumab, an immunotherapy drug for several cancers.",
          "Pembrolizumab blocks PD-1, helping the immune system fight cancer cells.",
          "The article discusses the impact of China's rise on the biopharma industry."
        ]
      },
      {
        "id": "cluster_15",
        "coverage": 1,
        "updated_at": "Mon, 15 Sep 2025 16:56:53 GMT",
        "title": "Maternity review 'will not deliver justice' - mum",
        "neutral_headline": "Maternity Review Will Not Deliver Justice, Says Mother",
        "items": [
          {
            "source": "BBC Health",
            "url": "https://www.bbc.com/news/articles/c36k5ee4nzlo?at_medium=RSS&at_campaign=rss",
            "published_at": "Mon, 15 Sep 2025 16:56:53 GMT",
            "title": "Maternity review 'will not deliver justice' - mum",
            "standfirst": "Lauren Caulfield was cared for at NHS hospitals in Leeds and Bradford before her daughter's death.",
            "content": "Lauren Caulfield was cared for at NHS hospitals in Leeds and Bradford before her daughter's death.",
            "feed_position": 2,
            "image_url": "https://ichef.bbci.co.uk/ace/standard/240/cpsprodpb/7621/live/a293d910-9251-11f0-84c8-99de564f0440.jpg"
          }
        ],
        "featured_image": "https://ichef.bbci.co.uk/ace/standard/240/cpsprodpb/7621/live/a293d910-9251-11f0-84c8-99de564f0440.jpg",
        "ai_summary": [
          "Lauren Caulfield received care at NHS hospitals in Leeds and Bradford.",
          "Her daughter's death prompted the statement about the maternity review.",
          "The article focuses on the mother's perspective on the review's impact.",
          "Details about the specific issues addressed in the review are not provided.",
          "The article highlights the mother's dissatisfaction with the review's outcome."
        ]
      },
      {
        "id": "cluster_16",
        "coverage": 1,
        "updated_at": "Mon, 15 Sep 2025 16:26:47 GMT",
        "title": "Hospital league tables will harm, not heal, the NHS | Letters",
        "neutral_headline": "Hospital League Tables Will Harm NHS, Readers Argue",
        "items": [
          {
            "source": "Guardian Health",
            "url": "https://www.theguardian.com/society/2025/sep/15/hospital-league-tables-will-harm-not-heal-the-nhs",
            "published_at": "Mon, 15 Sep 2025 16:26:47 GMT",
            "title": "Hospital league tables will harm, not heal, the NHS | Letters",
            "standfirst": "Readers respond to Wes Streeting’s introduction of hospital rankings in England based on 30 factorsWes Streeting does not seem to understand the complexity of healthcare funding. League tables will exacerbate regional differences rather than abolish them (Norfolk hospital worst in country as NHS league tables reintroduced, 9 September). The problems are not unknown but, sadly for this government, will not be solved in the next four years. It should not be a surprise, especially for Mr Streeting, that the NHS cannot function efficiently until social care is fixed.There is a massive shortage of staff in all specialities, which take 10 to 15 years to get from university to skilled professional. This leads to a reliance on locum and agency staff. The hospitals at the bottom of the tables will have the highest usage of them, reducing quality of care at a higher cost. Increasing the use of private clinics simply loses staff from the NHS. Continue reading...",
            "content": "Readers respond to Wes Streeting’s introduction of hospital rankings in England based on 30 factorsWes Streeting does not seem to understand the complexity of healthcare funding. League tables will exacerbate regional differences rather than abolish them (Norfolk hospital worst in country as NHS league tables reintroduced, 9 September). The problems are not unknown but, sadly for this government, will not be solved in the next four years. It should not be a surprise, especially for Mr Streeting, that the NHS cannot function efficiently until social care is fixed.There is a massive shortage of staff in all specialities, which take 10 to 15 years to get from university to skilled professional. This leads to a reliance on locum and agency staff. The hospitals at the bottom of the tables will have the highest usage of them, reducing quality of care at a higher cost. Increasing the use of private clinics simply loses staff from the NHS. Continue reading...",
            "feed_position": 12
          }
        ],
        "ai_summary": [
          "Readers respond to Wes Streeting's introduction of hospital rankings in England.",
          "They believe league tables will worsen regional differences in healthcare.",
          "The NHS cannot function efficiently until social care is fixed, according to readers.",
          "Staff shortages lead to reliance on locum staff, reducing care quality.",
          "Increasing private clinic use could further deplete NHS staff resources."
        ]
      },
      {
        "id": "cluster_17",
        "coverage": 1,
        "updated_at": "Mon, 15 Sep 2025 15:32:19 GMT",
        "title": "Why you might not need that magnesium supplement...",
        "neutral_headline": "Why you might not need that magnesium supplement",
        "items": [
          {
            "source": "BBC Health",
            "url": "https://www.bbc.com/news/videos/c9dx540q3y7o?at_medium=RSS&at_campaign=rss",
            "published_at": "Mon, 15 Sep 2025 15:32:19 GMT",
            "title": "Why you might not need that magnesium supplement...",
            "standfirst": "Drs Chris and Xand sit down with Professor Stella Volpe, the Head of the department of Nutrition, Food and Exercise at Virginia Tech in the US.",
            "content": "Drs Chris and Xand sit down with Professor Stella Volpe, the Head of the department of Nutrition, Food and Exercise at Virginia Tech in the US.",
            "feed_position": 101,
            "image_url": "https://ichef.bbci.co.uk/ace/standard/240/cpsprodpb/0212/live/b8798390-8eed-11f0-84c8-99de564f0440.jpg"
          }
        ],
        "featured_image": "https://ichef.bbci.co.uk/ace/standard/240/cpsprodpb/0212/live/b8798390-8eed-11f0-84c8-99de564f0440.jpg",
        "ai_summary": [
          "Drs Chris and Xand discuss magnesium supplements with Professor Stella Volpe.",
          "Professor Volpe is the Head of Nutrition, Food and Exercise at Virginia Tech.",
          "The discussion likely covers the necessity of magnesium supplementation.",
          "The article may explore the potential benefits and drawbacks of supplements.",
          "The focus is on providing expert insights into magnesium intake."
        ]
      },
      {
        "id": "cluster_18",
        "coverage": 1,
        "updated_at": "Mon, 15 Sep 2025 12:00:03 GMT",
        "title": "‘Americans should be alarmed’: Experts say loss of expertise at CDC will harm US health",
        "neutral_headline": "‘Americans should be alarmed’: Experts say loss of expertise at CDC will harm US health",
        "items": [
          {
            "source": "Guardian Health",
            "url": "https://www.theguardian.com/us-news/2025/sep/15/cdc-leadership-loss-experts-alarmed",
            "published_at": "Mon, 15 Sep 2025 12:00:03 GMT",
            "title": "‘Americans should be alarmed’: Experts say loss of expertise at CDC will harm US health",
            "standfirst": "Top officials exited agency under RFK Jr’s leadership, and his anti-vax beliefs have dismayed medical communityAfter high-profile departures and sweeping layoffs, the US Centers for Disease Control and Prevention (CDC) faces an unprecedented loss of expertise and a simultaneous erosion of trust as top health leaders undermine vaccines and other vital health tools.“Americans should be alarmed,” said Nirav Shah, former principal deputy director at CDC and now a visiting professor at Colby College. “All of these moves leave us less safe, and it comes at a time of rising public health threats.” Continue reading...",
            "content": "Top officials exited agency under RFK Jr’s leadership, and his anti-vax beliefs have dismayed medical communityAfter high-profile departures and sweeping layoffs, the US Centers for Disease Control and Prevention (CDC) faces an unprecedented loss of expertise and a simultaneous erosion of trust as top health leaders undermine vaccines and other vital health tools.“Americans should be alarmed,” said Nirav Shah, former principal deputy director at CDC and now a visiting professor at Colby College. “All of these moves leave us less safe, and it comes at a time of rising public health threats.” Continue reading...",
            "feed_position": 13
          }
        ],
        "ai_summary": [
          "The US Centers for Disease Control and Prevention faces expertise loss.",
          "High-profile departures and layoffs have occurred at the CDC.",
          "Top health leaders are undermining vaccines and other health tools.",
          "Nirav Shah, former CDC deputy director, expressed alarm about the situation.",
          "The article suggests these changes could make Americans less safe."
        ]
      },
      {
        "id": "cluster_19",
        "coverage": 1,
        "updated_at": "Mon, 15 Sep 2025 12:00:02 GMT",
        "title": "‘One jab will do the job’: Pakistan begins rollout of HPV vaccine to millions of girls",
        "neutral_headline": "‘One jab will do the job’: Pakistan begins rollout of HPV vaccine to millions of girls",
        "items": [
          {
            "source": "Guardian Health",
            "url": "https://www.theguardian.com/global-development/2025/sep/15/pakistan-hpv-vaccine-rollout-cervical-cancer",
            "published_at": "Mon, 15 Sep 2025 12:00:02 GMT",
            "title": "‘One jab will do the job’: Pakistan begins rollout of HPV vaccine to millions of girls",
            "standfirst": "Despite vaccination hesitancy, the end may be in sight for cervical cancer, which kills 64% of women with the diseaseThe questions come fast and furious: “Why only girls?”, “will it affect her periods?”, “can it cause infertility?”, “is it halal?” Inside the airy sports hall of Khatoon-e-Pakistan government girls’ school, the pupils in their crisp blue and white uniforms whisper among themselves, as their parents listen attentively to the health officials taking the session.While there are some fathers in the chairs laid out for the occasion, the majority are mothers. The groundwork is under way ahead of Pakistan’s first nationwide rollout of the human papillomavirus (HPV) vaccination campaign. Continue reading...",
            "content": "Despite vaccination hesitancy, the end may be in sight for cervical cancer, which kills 64% of women with the diseaseThe questions come fast and furious: “Why only girls?”, “will it affect her periods?”, “can it cause infertility?”, “is it halal?” Inside the airy sports hall of Khatoon-e-Pakistan government girls’ school, the pupils in their crisp blue and white uniforms whisper among themselves, as their parents listen attentively to the health officials taking the session.While there are some fathers in the chairs laid out for the occasion, the majority are mothers. The groundwork is under way ahead of Pakistan’s first nationwide rollout of the human papillomavirus (HPV) vaccination campaign. Continue reading...",
            "feed_position": 14
          }
        ],
        "ai_summary": [
          "Pakistan is starting a nationwide HPV vaccination campaign for girls.",
          "The campaign aims to combat cervical cancer, which has a high mortality rate.",
          "Questions about the vaccine's safety and efficacy are being addressed.",
          "The article describes the rollout process and community engagement.",
          "The goal is to reduce cervical cancer cases through vaccination."
        ]
      }
    ]
  },
  "month_in_research": {
    "updated_at": "2025-09-16T23:14:23.034Z",
    "clusters": []
  }
}